Bryson W. Katona, MD, PhD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Gastrointestinal Cancer Genetics Program, Hospital of the University of Pennsylvania
Director, Gastrointestinal Cancer Risk Evaluation Program, Hospital of the University of Pennsylvania
Member, Abramson Cancer Center - Cancer Control Program
Department: Medicine

Contact information
751 Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
South Pavilion
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Education:
MS (Chemistry)
University of Pennsylvania, 2002.
BA (Chemistry)
University of Pennsylvania, 2002.
PhD (Biochemistry)
Washington University in St. Louis School of Medicine, 2009.
MD
Washington University in St. Louis School of Medicine, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Hereditary gastrointestinal cancer and polyposis syndromes. Gastrointestinal cancer risk evaluation.

Description of Research Expertise

Hereditary gastrointestinal cancer and polyposis syndromes. Cellular signaling and epigenetic mechanisms of tumorigenesis in colon cancer and gastroenteropancreatic neuroendocrine tumors.

Selected Publications

Long JM, Powers JM, Katona BW: Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon. Gastrointest Endosc Clin N Am 32(1): 95-112, Jan 2022.

Williams S., Ebrahimzadeh J.E., Clay D., Constantino G., Heiman J., Valverde K., Katona B.W. : Comparison of outcomes between telemedicine and in-person gastrointestinal cancer risk evaluation appointments during the COVID-19 pandemic. Oral presentation at the Pennsylvania Association of Genetic Counselors Annual Spring Meeting 2022.

Gonda TA, Everett JN, Wallace M, Simeone DM; PRECEDE Consortium.: Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium. Gastroenterology 161(6): 1751-57, Dec 2021.

Cao Y, Feng Z, He X, Zhang X, Xing B, Wu Y, Hojnacki T, Katona BW, Ma J, Zhan X, Hua X.: Prolactin-regulated Pbk is involved in pregnancy-induced β-cell proliferation in mice. J Endocrinol 252(2): 107-123, Dec 2021.

DeJesse J., Vajravelu R., Dudzik C., Constantino G., Long J.M., Valverde K.D., Katona B.W.: Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome. Oral presentation at the Pennsylvania Association of Genetic Counselors Annual Spring Meeting – Virtual 12: 1023-1036, Nov 2021.

Gonda TA, Farrell J, Wallace M, Khanna L, Janec E, Kwon R, Saunders M, Siddiqui UD, Brand R, Simeone DM; PRECEDE Consortium.: Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium. Gastrointest Endosc S0016-5107(21): 01762-4, Nov 2021.

Rico K, Duan S, Pandey RL, Chen Y, Chakrabarti JT, Starr J, Zavros Y, Else T, Katona BW, Metz DC, Merchant JL: Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours. BMJ Open Gastroenterol 8(1): e000765, Nov 2021.

Katona BW, Long JM, Ahmad NA, Attalla S, Bradbury AR, Carpenter EL, Clark DF, Constantino G, Das KK, Domchek SM, Dudzik C, Ebrahimzadeh J, Ginsberg GG, Heiman J, Kochman ML, Maxwell KN, McKenna DB, Powers J, Shah PD, Wangensteen KJ, Rustgi AK: EUS-based Pancreatic Cancer Surveillance in BRCA1/BRCA2/PALB2/ATM Carriers Without a Family History of Pancreatic Cancer. Cancer Prev Res (Phila) 14(11): 1033-40, Nov 2021.

He X, Feng Z, Ma J, Zhang X, Ling S, Cao Y, Xing B, Wu Y, Wang L, Katona BW, June CH, Hua X.: CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch. Leukemia 35(11): 3309-3313, Nov 2021.

Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell M.: NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. J Natl Compr Canc Netw 19: 1122-1132, Oct 2021.

back to top
Last updated: 03/08/2022
The Trustees of the University of Pennsylvania